Eisai, Inc.

Form 483 issued October 27, 2023 · Kakamigahara, Japan

Inspection
Oct 23 – Oct 27, 2023
Observations
2
Pages
2
FEI number
3004967045

In short: On October 27, 2023, FDA issued a Form 483 with 2 observations to Eisai, Inc. in Kakamigahara, Gifu (FEI 3004967045) after an inspection that ran Oct 23 – Oct 27, 2023. The investigators were Ankur C. Patel and Bijoy Panicker. Most observations concern quality system and materials; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

Quality system and materials account for 2 of 2 observations.

Quality system1
Materials1

Most cited: 21 CFR 211.22(d) (1×) · 211.142(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Dmg products are not stored under appropriate conditions of hmnidity so that their identity, strength, quality…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Eisai, Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system and materials. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Eisai, Inc.?

Ankur C. Patel and Bijoy Panicker are named on this Form 483, for the inspection of Oct 23 – Oct 27, 2023. Each investigator has a profile showing what they cite most.

When was Eisai, Inc. inspected by FDA?

The inspection ran Oct 23 – Oct 27, 2023, and the Form 483 is dated October 27, 2023.

How do I get the full Form 483 for Eisai, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free